Catalyst: A Biopharmaceutical Company Focused on Rare Diseases
By A Mystery Man Writer
Description
Our company is committed to developing novel, safe, and efficacious therapies to improve the lives of people with rare diseases.
Rare Disease Day – Small Numbers, Big Challenges… and Big
Rachel Johnson on LinkedIn: Catalyst: A Biopharmaceutical Company
Muscular Dystrophy: FDA Approves Drug Developed By This Company
Catalyst Pharmaceuticals hit by FDA extra studies request for
Catalyst says pricey drug doing 'better than expected' despite
Top 32 Similar websites like fdatracker.com and alternatives
Top 32 Similar websites like fdatracker.com and alternatives
Catalyst Pharmaceuticals, Inc. on LinkedIn: Careers
If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago
Catalyst: A Biopharmaceutical Company Focused on Rare Diseases
Dan Brennan on LinkedIn: Catalyst: A Biopharmaceutical Company
from
per adult (price varies by group size)
